Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ring finger and FYVE like domain containing E3 ubiquitin protein ligase | 0.41 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||||
|
angiotensin II receptor associated protein | 0.890 | 0.115 | 0.19 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily A member regulatory beta subunit 1 | 0.821 | 0.115 | 4.2E-02 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
regulated endocrine specific protein 18 | 0.931 | 0.154 | 8.7E-10 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
cytochrome P450 family 4 subfamily F member 12 | 0.890 | 0.154 | 1.5E-17 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2005 | 2017 | ||||||||
|
cytochrome P450 family 4 subfamily A member 22 | 0.931 | 0.192 | 1.4E-29 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 2006 | 2008 | ||||||||
|
ectonucleoside triphosphate diphosphohydrolase 2 | 0.760 | 0.269 | 1.5E-14 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
thyrotropin releasing hormone receptor | 0.695 | 0.308 | 0.27 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 1995 | 2001 | ||||||||
|
myotrophin | 0.729 | 0.346 | 0.82 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 2002 | 2002 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 16 | 0.711 | 0.346 | 4.5E-04 |
|
group | 0.220 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
arginyl aminopeptidase | 0.705 | 0.385 | 2.6E-17 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 1985 | 1998 | ||||||||
|
potassium calcium-activated channel subfamily M regulatory beta subunit 1 | 0.716 | 0.423 | 2.1E-06 |
|
group | 0.550 | None | 1.000 | 2 | 0 | 2003 | 2010 | ||||||||
|
oxytocin/neurophysin I prepropeptide | 0.615 | 0.423 | 0.71 |
|
group | 0.500 | None | 1.000 | 2 | 0 | 1997 | 2008 | ||||||||
|
cytochrome c oxidase subunit 5B | 0.711 | 0.423 | 0.87 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
neuropeptide Y receptor Y1 | 0.628 | 0.423 | 4.3E-02 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2005 | 2009 | ||||||||
|
regulator of G protein signaling 5 | 0.647 | 0.423 | 5.3E-04 |
|
group | 0.550 | None | 1.000 | 1 | 0 | 1992 | 2018 | ||||||||
|
histamine receptor H3 | 0.647 | 0.462 | 4.1E-02 |
|
group | 0.500 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
cytochrome P450 family 4 subfamily A member 11 | 0.695 | 0.462 | 1.1E-24 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | 0.619 | 0.462 | 2.4E-07 |
|
group | 0.210 | None | 0.500 | 1 | 0 | 2009 | 2015 | ||||||||
|
arginine vasopressin receptor 1A | 0.663 | 0.500 | 6.9E-07 |
|
group | 0.240 | None | 1.000 | 2 | 0 | 2004 | 2019 | ||||||||
|
adducin 3 | 0.641 | 0.500 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 0.582 | 0.500 | 7.2E-08 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
potassium voltage-gated channel subfamily A member 5 | 0.606 | 0.500 | 1.1E-03 |
|
group | 0.230 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
ATPase plasma membrane Ca2+ transporting 1 | 0.666 | 0.500 | 1.00 |
|
group | 0.700 | None | 0.966 | 1 | 0 | 1999 | 2019 | ||||||||
|
quinoid dihydropteridine reductase | 0.691 | 0.500 | 1.5E-04 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 |